Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zai Lab is a leading innovative biopharmaceutical company based in China and the United States, focused on bringing transformative medicines to patients with cancer, autoimmune disorders, and infectious diseases. The company operates a sophisticated R&D center at 1095 Jiafang Road in Shanghai, which serves as a hub for its internal discovery and development efforts. Zai Lab has successfully commercialized several high-profile products in Greater China, including Zejula and Optune, through a combination of strategic global partnerships and internal development. Their business model emphasizes late-stage licensing of global assets for the China market alongside a growing pipeline of proprietary global programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Organization at 1095 Jiafang.